Scientific Programme

The programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world. The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focussed on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond. The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community.

Sunday 28 October
Monday 29 October
Tuesday 30 October
Wednesday 31 October

Sunday 28 October 2018

12:00–13:30Interactive Case Study Session
In collaboration with the University of Liverpool Drug Interactions website:

12.00–12.15HIV pharmacology in 2018
Saye Khoo, Molecular and Clinical Pharmacology, University of Liverpool, Liverpool,

12.15–12.40Case 1: TB co-infection
Marta Boffito, HIV and Sexual Health – Kobler Clinic, Chelsea Westminster
Hospital, London, UK

12.40–13.05Case 2: HIV-HCV and PWIDS
Erica Peters, Brownlee Centre for Infectious Diseases, NHS Greater Glasgow
Clyde, Glasgow, UK

13.05–13.30Case 3: Pregnancy
Mas Chaponda, Royal Liverpool and Broadgreen University Hospitals NHS Trust,
Liverpool, UK

Discussants:  Fiona Marra, Advanced Pharmacist HIV/HCV, Gartnavel Hospital,
Glasgow, UK
Mohammed Lamorde, Infectious Diseases Institute, Makerere University,
Kampala, Uganda


14:30–16:00Industry Symposium


16:30–16:45Official Opening
Andrew Phillips, University College London, London, UK
Welcome from Glasgow City

Representative from Glasgow City Council

16:45–17:30Joep Lange and Jacqueline van Tongeren Memorial Lecture
Lecture dedicated to Joep Lange and Jacqueline van Tongeren in recognition of
their commitment and passion to rid the world of HIV/AIDS


HIV/AIDS, global health and the Sustainable Development Goals
Kevin M De Cock, CDC Country Office, Nairobi, Kenya

17:30–18:30Keynote Lectures
Strategies to reduce HIV incidence in Europe
Anastasia Pharris, European Centre for Disease Prevention and Control (ECDC),
Sweden, Stockholm

PrEP: what’s happening in Europe and the World in general
Sheena McCormack, MRC Clinical Trials Unit at UCL, London, UK

18:30–19:30Welcome Reception

Back to the top of the page

Monday 29 October 2018

08:30–10:00Congress Plenary Session

08:30–08:50New ARV drugs and strategies
Alexandra Calmy, HIV/AIDS Unit, Geneva University Hospital, Geneva, Switzerland

08:50–09:10The top 10 DDIs in day to day clinical management of HIV
Catia Marzolini, Division of Infectious Diseases & Hospital Epidemiology,
University Hospital Basel, Basel, Switzerland

09:10–09:30Adverse effects of current ARVs: myths and realities
Patrick Mallon, Mater Misericordiae University Hospital, Dublin



10:30–11:15Lock Lecture
HIV Glasgow is honoured to have been chosen by the Royal College of
Physicians and Surgeons of Glasgow to present the Lock Lecture as part of
the Scientific Programme

Lock Lecture: introduction
Representative of the Royal College of Physicians and Surgeons of Glasgow,
Glasgow, UK

STIs among MSM: new challenges in prevention, diagnosis and treatment
Jean-Michel Molina, Department of Infectious Diseases and University of Paris 7,
St Louis Hospital, Paris, France

11:15–12:30Congress Plenary and Oral Paper

11:15–11:35Retention and re-engagement in care
Fiona Burns, Centre for Sexual Health & HIV Research and Royal Free Hospital,
London, UK

11:35–11:55Ageing successfully with HIV: challenges and goals
Julian Falutz, Department of Medicine, McGill University, Montreal, Canada

11:55–12:10Oral paper


12:30–14:00Scientific Posters and Lunch

12:45–13:45Poster Discussions Sessions

14:00–15:30Congress Plenary and Oral Papers

14:00–14:20Eliminating hepatitis C: a public health perspective
Margaret Hellard, Burnet Institute, Melbourne, Australia; and Viral Hepatitis Services,
Department of Infectious Diseases, The Alfred Hospital Melbourne, Australia 

14:20–14:40HIV and migration: a renewed challenge
Julia Del Amo, National Center for Epidemiology, Institute of Health Carlos III,
Madrid, Spain

14:40–14:55Oral paper

14:55–15:10Oral paper


15:30–17:00Challenging Cases in HIV
In collaboration with the International Antiviral Society-USA (IAS-USA)

15.30–15.40Welcome and introduction
Carlos del Rio

15.40–16.05Case 1: ART – initiating treatment
Chloe Orkin, Ambrose King Centre, Royal London Hospital, London, UK

16.05–16.30Case 2: PrEP to PEP conversion
Roy M Gulick, Weill Cornell Medicine, New York, NY, USA

16.30–17.00Case 3: ART – treatment failure
Manuel Battegay, Division of Infectious Diseases and Hospital Epidemiology,
University Hospital Basel, Basel, Switzerland

Panel:Manuel Battegay
Carlos del Rio
Roy M Gulick
Chloe Orkin
Ian Williams


17:30–19:00Industry Symposium

Back to the top of the page

Tuesday 30 October 2018

08:30–10:00Industry Symposium


10:30–12:30Congress Plenary Session and Oral Papers

10:30–10:50Approaches towards a cure for HIV
Sarah Fidler, Department of GUM and HIV Medicine, Imperial College and
Imperial College NHS Trust, London UK

10:50–11:10HIV cure and cancer immunotherapy: cross-disciplinary research at its best
Steven G Deeks, Department of Medicine, University of California,
San Francisco, CA, USA 

11:10–11:25Oral paper

11:25–11:40Oral paper

11:40–11:55Oral paper


12:30–14:00Scientific Posters and Lunch

12:45–13:45EATG Session 
In collaboration with the European AIDS Treatment Group (EATG)

14:00–15:30#Adolescent Lives Matter
In collaboration with the International AIDS Society (IAS)

15.00-15.15Living with it – complications of long term HIV

15.15-15.30Taking it – PrEP experiences among adolescent MSM

15.30-15.45Staying with it- novel ways to increase adolescent adherence

15.45-16.00Dealing with it – mental health and stigma: report from a cohort of YPLHIV
in the Ukraine

16.00-16.15Adolescent friendly – really?

16.15-16.30Panel Discussion

15:30–17:00Mental Health and HIV: what we all need to know
In collaboration with the British HIV Association (BHIVA)
Co-Chair:Tamás Bereczky, European AIDS Treatment Group, Budapest, Hungary
Chloe Orkin, Ambrose King Centre, Royal London Hospital,
London, UK; and Chair, BHIVA

15.30–15.40Introduction: BHIVA Mental Health Audit
Chloe Orkin

15.40–15.55Prevalence data 
Fiona Lampe, Infection & Population Health, University College London, London, UK

15.55–16.10Discrimination in EU healthcare, the community perspective 

16.10–16.25Important DDI: to include QT/PR interval concerns
Laura Waters, Mortimer Market Centre, University College London Hospitals,
London, UK

16.25–16.40Managing insomnia 

16.40–17.00Q & A 


17:30–19:00Industry Symposium

19:00–19:45Poster reception

Back to the top of the page

Wednesday 31 October 2018

08:30–10:00 Congress Plenary Session

08:30–08:50Prospects for TB epidemic control: updates in evidence 
Graeme Meintjes, University of Cape Town, Cape Town, South Africa

08:50–09:05Oral paper

09:05–09:20Oral paper

09:20–09:35Oral paper



10:30–12:00What Women Want
In collaboration with the European AIDS Clinical Society (EACS) and Women
Against Viruses in Europe (WAVE)

Co-Chairs:Justyna D Kowalksa, Hospital for Infectious Diseases, Medical
University of Warsaw, Warsaw, Poland
Fiona Mulcahy, Department of Genito-Urinary Medicine & Infectious
Diseases, St James’ Hospital, Dublin, Ireland

10:30–10:55PrEP for women in Europe: case presentation and lecture
Agnieska Wroblewska, HIV Out-Patient CLinic, Hospital for Infectious Diseases,
Warsaw, Poland (Case) 

Nneka Nwokolo, Sexual Health and HIV Medicine, Chelsea and Westminster
Hospital, London, UK (Lecture)

10:55–11:20Pharmacokinetic studies in women and its impact on clinical practice: case
presentation and lecture  

Eugénie Colin-Benoit, Department of Infectious Diseases, University Hospital Bern,
Bern, Switzerland (Case)

Karoline Aebi-Popp, Department of Infectious Diseases, University Hospital Bern,
Bern, Switzerland (Lecture)

11:20–11:45HCV treatment and pregnancy: case presentation and lecture 
Marta Vasylyev, Out Patient Department, Lviv Regional AIDS Center,
Lviv, Ukraine (Case)

Karine Lacombe, Infectious and Tropical Diseases Department, Saint Antoine
Hospital (AP-HP), Paris, France (Lecture)

11:45–12:00Oral paper

12:00–13:30Scientific Posters and Lunch

12:15–13:15Poster Discussions Sessions

13:30–15:00Late Breakers/Hot Topics

15:00–15:10Congress Closing Remarks
European AIDS Treatment Group
Andrew Phillips

Back to the top of the page